Document And Entity Information
Aug. 12, 2019
Cover [Abstract]  
Document Type 8-K/A
Amendment Flag true
Amendment Description This Form 8-K/A is being filed to disclose that on October 2, 2019 the Board appointed Dr. Hack to the Audit Committee of the Board, effective immediately, and determined that Dr. Hack is independent under applicable U.S. Securities and Exchange Commission requirements and the Nasdaq listing standards.
Document Period End Date Aug. 12, 2019
Entity Registrant Name Dynavax Technologies Corp
Entity Central Index Key 0001029142
Entity Emerging Growth Company false
Entity File Number 001-34207
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 33-0728374
Entity Address, Address Line One 2100 Powell Street
Entity Address, Address Line Two Suite 900
Entity Address, City or Town Emeryville
Entity Address, State or Province CA
Entity Address, Postal Zip Code 94608
City Area Code 510
Local Phone Number 848-5100
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of each class: Common Stock, $0.001 par value
Trading symbol(s): DVAX
Name of each exchange on which registered: NASDAQ